Checkmate Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Checkmate Pharmaceuticals generated cash of -$53,715,000, which is less than the previous year. Cash used in financing activities reached the amount of $146,000 last year. Net change in cash is therefore $7,620,000.
Cash Flow
| 2018 | -20.42M | 0 | 10.92M |
|---|---|---|---|
| 2019 | -26.85M | 0 | 18.97M |
| 2020 | -38.11M | -83.29M | 160.27M |
| 2021 | -53.71M | 61.18M | 146K |
CMPI Cash Flow Statement (2018 – 2021)
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Cash at beginning of period | 43.07M | 4.20M | 12.07M | 21.57M |
Operating activities | ||||
Net income | -61.40M | -36.90M | -28.29M | -20.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 66K | 188K | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 1.08M | 63K | 606K | 118K |
Cash generated by operating activities | -53.71M | -38.11M | -26.85M | -20.42M |
Investing activities | ||||
Purchases Of Investments | -10.23M | -83.29M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 61.18M | -83.29M | 0 | 0 |
Financing activities | ||||
Common Stock Issued | 0 | 67.71M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 146K | 160.27M | 18.97M | 10.92M |
Net Change In Cash | 7.62M | 38.87M | -7.87M | -9.49M |
Cash at end of period | 50.69M | 43.07M | 4.20M | 12.07M |
| Data source | Data source |